Skip to main content

Peer Review reports

From: Early clinical experience with eptinezumab: results of a retrospective observational study of patient response in the United States

Original Submission
12 Aug 2022 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
10 Oct 2022 Reviewed Reviewer Report
4 Mar 2023 Reviewed Reviewer Report
3 Apr 2023 Author responded Author comments - Amaal J. Starling
Resubmission - Version 3
3 Apr 2023 Submitted Manuscript version 3
6 Apr 2023 Reviewed Reviewer Report
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
11 Apr 2023 Editorially accepted
20 Apr 2023 Article published 10.1186/s12883-023-03204-8

You can find further information about peer review here.

Back to article page